carvedilol has been researched along with mocetinostat in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (35.29) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, PA; DiMartino, MJ; Griswold, DE; Hillegass, LM; Slivjak, MJ; Smith, EF | 1 |
| Bril, A; DiMartino, MJ; Feuerstein, GZ; Linee, P; Poyser, RH; Ruffolo, RR; Slivjak, M; Smith, EF | 1 |
| Christopher, TA; Feuerstein, GZ; Lopez, BL; Ma, XL; Ruffolo, RR; Yue, TL | 2 |
| Arch, JR; Cheng, HY; Feuerstein, G; Hieble, JP; Liu, GL; Ma, XL; Ruffolo, RR; Yue, TL | 1 |
| Brunvand, H; Feuerstein, GZ; Liu, G; Ma, XL; Ruffolo, RR; Yue, TL | 1 |
| Chen, J; Christopher, TA; Gao, F; Gu, J; Lopez, BL; Lysko, P; Ma, XL; Ohlstein, EH; Ruffolo, RR; Yue, TL | 1 |
| Cíz, M; Drábiková, K; Fábryová, V; Jancinová, V; Lojek, A; Nosál, R | 1 |
| Holománová, D; Macicková, T; Nosál', R; Pecivová, J | 1 |
| Cíz, M; Gallova, L; Holománová, D; Lojek, A; Macicková, T; Nosál', R; Pecivová, J | 2 |
| Jaggi, AS; Sharma, A; Singh, D; Singh, M; Singh, N | 1 |
| Cupanikova, D; Lojek, A; Macickova, T; Nosal, R; Pecivova, J; Pekarova, M | 1 |
| Araújo Júnior, RF; Brito, GA; de Araújo, AA; Garcia, VB; Guedes, PM; Leitão, RF; Miguel, Ede C | 1 |
| Abo-Saif, AA; Ahmed, YM; Messiha, BA | 1 |
| Ahmed, MAE; El Morsy, EM | 1 |
| Ali, FE; Hassan, MI; Shalkami, AS | 1 |
17 other study(ies) available for carvedilol and mocetinostat
| Article | Year |
|---|---|
Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Neutrophils; Peroxidase; Propanolamines; Rats; Rats, Inbred Strains; Vasodilator Agents | 1992 |
Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Disease Models, Animal; Heart Rate; Myocardial Infarction; Myocardium; Peroxidase; Propanolamines; Propranolol; Swine; Swine, Miniature; Vasodilator Agents | 1992 |
Carvedilol, a new beta-adrenoreceptor blocker, vasodilator and free-radical scavenger, exerts an anti-shock and endothelial protective effect in rat splanchnic ischemia and reperfusion.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Endothelium, Vascular; Free Radical Scavengers; Hematocrit; Male; Mesenteric Vascular Occlusion; Neutrophils; Peroxidase; Propanolamines; Rats; Rats, Sprague-Dawley; Reperfusion; Shock; Superoxide Dismutase; Vasodilator Agents | 1995 |
Effects of a hydroxylated metabolite of the beta-andrenoreceptor antagonist, carvedilol, on post-ischaemic splachnic tissue injury.
Topics: Adrenergic beta-Antagonists; Animals; Antioxidants; Blood Pressure; Carbazoles; Carvedilol; Endothelium, Vascular; In Vitro Techniques; Ischemia; Male; Mesenteric Artery, Superior; Muscle Relaxation; Muscle, Smooth, Vascular; Peroxidase; Propanolamines; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 1998 |
Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antioxidants; Blood Pressure; Carbazoles; Carvedilol; Heart Rate; Male; Metoprolol; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oxidation-Reduction; Peroxidase; Propanolamines; Propranolol; Rabbits; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Recombinant Proteins; Solubility; Ventricular Function, Left; Ventricular Pressure | 1998 |
SB 211475, a metabolite of carvedilol, reduces infarct size after myocardial ischemic and reperfusion injury in rabbits.
Topics: Adrenergic alpha-Antagonists; Animals; Antioxidants; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Hemodynamics; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Peroxidase; Propanolamines; Rabbits | 1998 |
Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Antioxidants; Bisoprolol; Carbazoles; Cardiovascular Agents; Carvedilol; Creatine Kinase; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Isoproterenol; Lipid Peroxidation; Male; Membrane Lipids; Myocardial Ischemia; Myocardium; Peroxidase; Propanolamines; Rabbits; Reperfusion Injury; Ventricular Pressure | 2000 |
Inhibition of chemiluminescence by carvedilol in the cell-free system, whole human blood and blood cells.
Topics: Adult; Blood Cells; Blood Platelets; Carbazoles; Carvedilol; Cell Line, Tumor; Cell-Free System; Enzyme Inhibitors; Humans; Kinetics; Leukocytes; Luminescent Measurements; Male; Middle Aged; Peroxidase; Propanolamines; Reactive Oxygen Species | 2005 |
Influence of carvedilol on superoxide generation and enzyme release from stimulated human neutrophils.
Topics: Antihypertensive Agents; Antioxidants; Carbazoles; Carvedilol; Humans; In Vitro Techniques; Neutrophil Activation; Neutrophils; Peroxidase; Propanolamines; Superoxides | 2005 |
In vitro effect of carvedilol on professional phagocytes.
Topics: Androstadienes; Animals; Blotting, Western; Carbazoles; Cardiovascular Agents; Carvedilol; Cell Line; Dose-Response Relationship, Drug; Humans; Luminescence; Male; Mice; N-Formylmethionine Leucyl-Phenylalanine; Nitric Oxide; Nitric Oxide Synthase Type II; Peroxidase; Phagocytes; Propanolamines; Spectrophotometry; Superoxides; Wortmannin | 2007 |
Effect of carvedilol on reactive oxygen species and enzymes linking innate and adaptive immunity.
Topics: Animals; Carbazoles; Carvedilol; Cells, Cultured; Immunity, Cellular; Immunity, Innate; Macrophages; Mice; N-Formylmethionine Leucyl-Phenylalanine; Nitric Oxide Synthase Type II; Peroxidase; Propanolamines; Reactive Oxygen Species; Superoxides | 2006 |
Cardioprotective effects of mast cell modulators in ischemia-reperfusion-induced injury in rats.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Creatine Kinase; Histamine H1 Antagonists; In Vitro Techniques; Ketotifen; L-Lactate Dehydrogenase; Male; Mast Cells; Myocardial Reperfusion Injury; p-Methoxy-N-methylphenethylamine; Peroxidase; Propanolamines; Rats; Rats, Wistar | 2007 |
Inhibition of superoxide generation and myeloperoxidase release by carvedilol after receptor and nonreceptor stimulation of human neutrophils.
Topics: Adrenergic beta-Antagonists; Androstadienes; Calcimycin; Carbazoles; Carvedilol; Humans; In Vitro Techniques; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxidants; Peroxidase; Phosphatidylinositol 3-Kinases; Propanolamines; Protein Kinase C; Receptors, Adrenergic, beta; Stimulation, Chemical; Superoxides; Tetradecanoylphorbol Acetate; Wortmannin | 2008 |
Carvedilol Improves Inflammatory Response, Oxidative Stress and Fibrosis in the Alcohol-Induced Liver Injury in Rats by Regulating Kuppfer Cells and Hepatic Stellate Cells.
Topics: Animals; Biomarkers; Carbazoles; Carvedilol; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; Ethanol; Gene Expression Regulation; Glutathione Peroxidase; Hepatic Stellate Cells; Immunohistochemistry; Kupffer Cells; Liver Cirrhosis; Male; Malondialdehyde; Oxidative Stress; Peroxidase; Propanolamines; Rats; RNA, Messenger; Superoxide Dismutase | 2016 |
Granisetron and carvedilol can protect experimental rats againstadjuvant-induced arthritis.
Topics: Animals; Arthritis, Experimental; Biomarkers; Carbazoles; Cartilage Oligomeric Matrix Protein; Carvedilol; Female; Granisetron; Immunoglobulin G; Matrix Metalloproteinase 3; Peroxidase; Propanolamines; Rats; Rats, Wistar; Rheumatoid Factor | 2017 |
Carvedilol attenuates l-arginine induced acute pancreatitis in rats through modulation of oxidative stress and inflammatory mediators.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Arginine; Biomarkers; C-Reactive Protein; Carvedilol; Glutathione; Hydrolases; Interleukin-1beta; Male; Malondialdehyde; Oxidative Stress; Pancreatitis; Peroxidase; Rats; Tumor Necrosis Factor-alpha | 2020 |
Role of TLR-4/IL-6/TNF-α, COX-II and eNOS/iNOS pathways in the impact of carvedilol against hepatic ischemia reperfusion injury.
Topics: Adrenergic Antagonists; Animals; Anti-Inflammatory Agents; Carvedilol; Cyclooxygenase 2; Interleukin-6; Liver; Liver Diseases; Male; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxidase; Rats, Wistar; Reperfusion Injury; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2021 |